Introduction to drug utilization research

Björn Wettermark, Monique Elseviers, Tanja Mueller, Anna Birna Almarsdottir, Ria Benkő, Marion Bennie, Irina Iaru, Katarina Gvozdanović, Mikael Hoffmann, Verica Ivanovska, Seán MacBride-Stewart, Elisabetta Poluzzi, Lisa G. Pont, Hege Salvesen Blix, Gabriel Sanfelix-Gimeno, Gisbert W. Selke, Katja Taxis, Ana Tomas Petrović, Indrė Trečiokienė, Sabine Vogler

Publikation: Bidrag til bog/antologi/rapportBidrag til bog/antologiForskningpeer review

1 Citationer (Scopus)

Abstract

Research in drug utilization began to develop in the 1960s. Some pioneering studies focused on assessing differences in drug utilization between countries or regions. Other studies focused on factors influencing the prescribing patterns of physicians. Drug utilization research (DUR) is significantly connected to clinical pharmacology. The original aims of clinical pharmacology were to develop new drugs and to determine the balance between drug benefit and risk in clinical trials. The eclectic nature of drug utilization research requires expertise in a broad range of research methodologies. Qualitative studies are also needed to explore the perceptions of prescribers, dispensers and patients in dealing with medicines. These studies are extremely important to gain a deeper understanding of various phenomena in drug utilization. The nature of the scientific questions and the types of drug utilization studies vary across the world.

OriginalsprogEngelsk
TitelDrug Utilization Research : Methods and Applications
ForlagWiley
Publikationsdato2024
Udgave2
Sider1-13
Kapitel1
ISBN (Trykt)9781119911654
ISBN (Elektronisk)9781119911685
DOI
StatusUdgivet - 2024

Bibliografisk note

Publisher Copyright:
© 2024 John Wiley & Sons Ltd.

Citationsformater